Fisher & Paykel Healthcare Corporation Limited today announced it will hold a technical briefing day for analysts and investors in Sydney on Tuesday 13 October 2015.
The Investor Day will provide investors with the opportunity to meet senior management and hear presentations on our products, their clinical benefits and our growth opportunities.
Interested analysts and investors may request an invitation by contacting Fisher & Paykel Healthcare’s Investor Relations Manager, Marcus Driller, at firstname.lastname@example.org.
Fisher & Paykel Healthcare Announces 2015 Investor Day
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Providing Optimal Humidity for intubated patients
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
This access is intended for health professionals only and by accessing it you agree to be a health professional.
I am a health professional. P>
Remember my choice